PL1761257T3 - Zastosowanie acetylo-L-karnityny podczas przygotowania leku do leczenia bólu neuropatycznego u pacjentów cukrzycowych - Google Patents
Zastosowanie acetylo-L-karnityny podczas przygotowania leku do leczenia bólu neuropatycznego u pacjentów cukrzycowychInfo
- Publication number
- PL1761257T3 PL1761257T3 PL05730316T PL05730316T PL1761257T3 PL 1761257 T3 PL1761257 T3 PL 1761257T3 PL 05730316 T PL05730316 T PL 05730316T PL 05730316 T PL05730316 T PL 05730316T PL 1761257 T3 PL1761257 T3 PL 1761257T3
- Authority
- PL
- Poland
- Prior art keywords
- carnitine
- acetyl
- medicine
- preparation
- treatment
- Prior art date
Links
- RDHQFKQIGNGIED-MRVPVSSYSA-N O-acetyl-L-carnitine Chemical compound CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C RDHQFKQIGNGIED-MRVPVSSYSA-N 0.000 title 1
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 208000004296 neuralgia Diseases 0.000 title 1
- 208000021722 neuropathic pain Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000327A ITRM20040327A1 (it) | 2004-07-01 | 2004-07-01 | Uso della acetil l-carnitina per la preparazione di un medicamento per il trattamento del dolore neuropatico in pazienti diabetici. |
| EP05730316.6A EP1761257B1 (en) | 2004-07-01 | 2005-04-05 | Use of acetyl l-carnitine for the preparation of a medicine for the treatment of neuropathic pain in diabetic patients |
| PCT/EP2005/003557 WO2006002698A1 (en) | 2004-07-01 | 2005-04-05 | Use of acetyl l-carnitine for the preparation of a medicine for the treatment of neuropathic pain in diabetic patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1761257T3 true PL1761257T3 (pl) | 2015-06-30 |
Family
ID=34965656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05730316T PL1761257T3 (pl) | 2004-07-01 | 2005-04-05 | Zastosowanie acetylo-L-karnityny podczas przygotowania leku do leczenia bólu neuropatycznego u pacjentów cukrzycowych |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20060004095A1 (enExample) |
| EP (1) | EP1761257B1 (enExample) |
| JP (1) | JP5519907B2 (enExample) |
| KR (1) | KR101176347B1 (enExample) |
| CA (1) | CA2570268C (enExample) |
| CY (1) | CY1116171T1 (enExample) |
| DK (1) | DK1761257T3 (enExample) |
| ES (1) | ES2532497T3 (enExample) |
| IT (1) | ITRM20040327A1 (enExample) |
| MX (1) | MXPA06014907A (enExample) |
| PL (1) | PL1761257T3 (enExample) |
| PT (1) | PT1761257E (enExample) |
| SI (1) | SI1761257T1 (enExample) |
| WO (1) | WO2006002698A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU230002B1 (en) * | 2000-12-15 | 2015-04-28 | Sigma Tau Ind Farmaceuti | Use of l-carnitine for preparation of compositions for stabilizing the proteins |
| US8173618B2 (en) * | 2003-07-25 | 2012-05-08 | University Of Massachusetts | Formulations for reducing neuronal degeneration |
| US8597640B2 (en) * | 2007-10-31 | 2013-12-03 | University Of Massachusetts Lowell | Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1133010B (it) * | 1980-05-15 | 1986-07-09 | Sigma Tau Ind Farmaceuti | Metodo terapuetico per il trattamento del diabete mellito a insorgenza giovanile e composizione farmaceutica per tale metodo |
| IT1196564B (it) * | 1986-08-04 | 1988-11-16 | Sigma Tau Ind Farmaceuti | Impiego di acetil l-carnitina nel trattamento terapeutico delle neuropatie periferiche |
| IT1224842B (it) * | 1988-12-27 | 1990-10-24 | Sigma Tau Ind Farmaceuti | Uso di derivati della l-carnitina nel trattamento terapeutico delle alterazioni degenerative del sistema nervoso |
| IT1263004B (it) * | 1992-10-08 | 1996-07-23 | Sigma Tau Ind Farmaceuti | Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti. |
| US5827886A (en) * | 1997-05-07 | 1998-10-27 | Thione International, Inc. | Composition for relief of arthritis-induced symptoms |
| IT1294227B1 (it) * | 1997-08-01 | 1999-03-24 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica contenente l-carnitina o una alcanoil l-carnitina e alcoli alifatici a lunga catena utile per la prevenzione |
| IT1306178B1 (it) * | 1999-07-27 | 2001-05-30 | Sigma Tau Ind Farmaceuti | Uso della l-carnitina e dei suoi alcanoil derivati per la preparazionedi un medicamento utile nel trattamento del paziente affetto da |
| ITRM20010294A1 (it) * | 2001-05-29 | 2002-11-29 | Sigma Tau Ind Farmaceuti | Uso della acetil l-carnetina in associazione con la biotina per il trattamento di pazienti affetti da diabete mellito di tipo ii insulino re |
-
2004
- 2004-07-01 IT IT000327A patent/ITRM20040327A1/it unknown
- 2004-10-21 US US10/969,217 patent/US20060004095A1/en not_active Abandoned
-
2005
- 2005-04-05 SI SI200531946T patent/SI1761257T1/sl unknown
- 2005-04-05 PT PT57303166T patent/PT1761257E/pt unknown
- 2005-04-05 KR KR1020077000584A patent/KR101176347B1/ko not_active Expired - Fee Related
- 2005-04-05 PL PL05730316T patent/PL1761257T3/pl unknown
- 2005-04-05 WO PCT/EP2005/003557 patent/WO2006002698A1/en not_active Ceased
- 2005-04-05 JP JP2007519628A patent/JP5519907B2/ja not_active Expired - Fee Related
- 2005-04-05 CA CA2570268A patent/CA2570268C/en not_active Expired - Lifetime
- 2005-04-05 US US11/570,484 patent/US20070213408A1/en not_active Abandoned
- 2005-04-05 DK DK05730316T patent/DK1761257T3/en active
- 2005-04-05 ES ES05730316.6T patent/ES2532497T3/es not_active Expired - Lifetime
- 2005-04-05 EP EP05730316.6A patent/EP1761257B1/en not_active Expired - Lifetime
- 2005-04-05 MX MXPA06014907A patent/MXPA06014907A/es not_active Application Discontinuation
-
2015
- 2015-03-23 CY CY20151100283T patent/CY1116171T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2570268C (en) | 2013-10-15 |
| JP5519907B2 (ja) | 2014-06-11 |
| SI1761257T1 (sl) | 2015-04-30 |
| ITRM20040327A1 (it) | 2004-10-01 |
| EP1761257A1 (en) | 2007-03-14 |
| ES2532497T3 (es) | 2015-03-27 |
| DK1761257T3 (en) | 2015-03-23 |
| PT1761257E (pt) | 2015-04-14 |
| KR20070042963A (ko) | 2007-04-24 |
| MXPA06014907A (es) | 2007-03-21 |
| CA2570268A1 (en) | 2006-01-12 |
| CY1116171T1 (el) | 2017-02-08 |
| WO2006002698A1 (en) | 2006-01-12 |
| JP2008505134A (ja) | 2008-02-21 |
| EP1761257B1 (en) | 2014-12-31 |
| US20060004095A1 (en) | 2006-01-05 |
| KR101176347B1 (ko) | 2012-08-24 |
| US20070213408A1 (en) | 2007-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP2644A (en) | Traditional chinese medicine preparation for cardiocerebral blood vessel diseases and its preparing method | |
| ZA200805716B (en) | Use of nitrooxyderivative of drug for the treatment of muscular dystrophies | |
| PL2134259T3 (pl) | Urządzenie do nakłuwania skóry pacjenta | |
| GB2439393B (en) | Cannabinoids for use in the treatment of neuropathic pain | |
| IL242537A (en) | (s) –n– (3– chloro – 4 – cyanophenyl) –3– (4 – cyanophenoxy) –2 – hydroxy – 2 – methylpropanamide for the preparation of cancer and other disease treatment | |
| IL186662A (en) | Use of bis (thiohydrazide amide) to prepare a drug for the treatment of human cancer | |
| IL187220A (en) | Use of sodium arsenite sodium in the preparation of a drug for the treatment of metastatic tumor diseases | |
| PL2104452T3 (pl) | Urządzenie do nakłuwania skóry pacjenta | |
| GB0516601D0 (en) | Further medical use of a botanical drug or dietary supplement | |
| ZA200710800B (en) | Melthod and apparatus for the non-invasive sensing of glucose in a human subject | |
| EP2063902A4 (en) | THERAPEUTIC CELL MEDICAMENT WITH STEM CELLS OF SKIN | |
| IL205290A (en) | A variant of human neurorthin protein, or its active biological part, containing medicinal preparations, and its use in the preparation of therapeutic drugs | |
| ZA201003291B (en) | Device for delivering a plurality of medical treatment liquids to a human or animal patient | |
| AP2008004379A0 (en) | Use of agomelatine in obtaining medicaments intended for the treatment of sleep disorder in the depressed patient | |
| PL1761257T3 (pl) | Zastosowanie acetylo-L-karnityny podczas przygotowania leku do leczenia bólu neuropatycznego u pacjentów cukrzycowych | |
| GB2435425B (en) | Medical wound healing treatment | |
| GB0603630D0 (en) | Medical wound healing treatment | |
| PL2160213T3 (pl) | Zestaw do pozaustrojowej obróbki biologicznego płynu pacjenta oraz urządzenie wyposażone we wspomniany zestaw | |
| HRP20130319T1 (hr) | Upotreba kombinacije koju äśine l-karnitin ili alkanoil-l-karnitin, benzokinon topljiv u lipidima i omega-3-polinezasiä†ena masna kiselina, u pripravi dodatka za prehranu ili medikamenta za lijeäśenje bolesti rožnice | |
| HUP0402381A3 (en) | Monohydroxycarbamazepine for use in the preparation of a medicament for the treatment of affective and attention disorder and neuropathic pain | |
| IL218069A (en) | Oligoscride compounds, drug, pharmaceutical, and compound for its use in therapy | |
| EP1774975A4 (en) | USE OF A HUMAN LYSOZYM PREPARATION FOR THE TREATMENT OF ACNE | |
| GB0524514D0 (en) | Medical wound healing treatment | |
| EP1945171A4 (en) | MANUFACTURE OF A MEDICAL DEVICE AND USE IN ALTERNATIVE MEDICINE FOR REHABILITATION TREATMENT OF CHRONIC DISEASES | |
| IL200192A (en) | Use of l-cannitin and / or alkonial l-carnitine, or their common pharmaceutical salt, in combination with statin, for the preparation of a drug for the treatment of type 2 diabetes |